Essilorluxottica enters the medicine sector and does it by signing an agreement for the acquisition of ophthalmic clinics Optegra from Mideuropa. All in the context of the expansion strategy in the field of medical technology of the Franco-Italian group leader in the eyewear, according to what is announced on Friday by the companies. The operation should end by the end of the year but the financial details of the operation have not been disclosed.
What does Optegra deals with
The Optegra group offers treatments and procedures for the correction of the vision supported by artificial intelligence in the pre and post-operative phases. Among these:
- Safevista surgery of the cataract;
- therapies for macular degeneration linked to age and glaucoma;
- replacement of the refractive crystalline;
- laser surgery.
With his highly qualified surgeons and his dedicated medical teams, Opture has built a solid clinical leadership and an authoritative reputation based on the excellence of care and on cutting -edge results in the sector. He thus found space perfectly in the Med-Tech portfolio in continuous expansion of Essilorluxottica.
Optegra manages more than 70 eye hospitals and diagnostic structures in the United Kingdom, Czech Republic, Poland, Slovakia and the Netherlands. The platform offers ophthalmic treatments and elective vision correction procedures, supported by artificial intelligence during the pre and post-operative phases.
Not only glasses: what is the same of Essilorluxottica
For some time, Essilorluxottica has embarked on a strategic path of expansion and diversification of its business, aiming to overcome the traditional core linked exclusively to the production of frames and glasses for glasses. The company is gradually expanding its range to high potential segments and adjacent to its reference market, with the aim of establishing itself as a significant actor also in the world of lifestyle and wearable technology.
A concrete example of this strategy was had last Octoberwhen the group has aimed at the acquisition of Supreme, the famous New York brand known for its urban style and to be a point of reference in the sector of lifestyle high -end. The operation represented an important step towards the integration between fashion and glasses, strengthening the presence of the group even among younger consumers and attentive to trends. At the same time, the projects developed in collaboration with HalfMark Zuckerberg’s company, in the context of the Ray-Ban Meta smart glasses.
The acquisition operation was conducted with the support of Mideuropaa private equity fund based in Warsaw, specialized in investments in central-eastern Europe. Mideuropa currently manages a portfolio of about 6.5 billion euros, mainly focusing on small and medium -sized high potential companies. The Fund usually invests through the acquisition of majority or minority shares, with tickets between 30 and 50 million euros, actively contributing to the development and growth of the companies in which it enters participation.
Milleri (ad Essilorluxottica): “New clinical skills in our group”
The CEO of Esilux Francesco Milleri And his deputy Paul du saillant said:
“With the acquisition of Optegra, we enter today in a new dimension, in which paths complete with vision care, advanced diagnostics, therapeutic treatments and eye surgery converge in a single integrated platform. Thanks to the experience of its medical teams, Optegra will bring new clinical skills within our group, allowing us to respond to the needs of patients with technologies and treatments for the care of vision more and more At the forefront, perfectly integrated into a reliable ecosystem that will give concrete form to our ambitions in the Med-Tech “.
